Company Filing History:
Years Active: 1998
Title: Uwe Peterson: Innovator in Antibacterial Compounds
Introduction
Uwe Peterson is a notable inventor based in Leverkusen, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial agents. His work has implications for the treatment of various bacterial infections, showcasing the importance of innovation in healthcare.
Latest Patents
Uwe Peterson holds a patent for "Quinolone- and naphthyridonecarboxylic acid derivatives." This invention relates to new compounds that are substituted in the 7-position by a tricyclic amine radical. The patent also covers their salts, processes for their preparation, and antibacterial compositions that include these compounds. This innovation represents a step forward in the search for effective antibacterial treatments.
Career Highlights
Uwe Peterson is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to focus on the development of new therapeutic agents, contributing to the company's reputation for innovation in the pharmaceutical industry.
Collaborations
Throughout his career, Uwe Peterson has collaborated with several colleagues, including Thomas Schenke and Thomas Jaetsch. These collaborations have fostered a productive environment for research and development, leading to advancements in the field of medicinal chemistry.
Conclusion
Uwe Peterson's contributions to the field of antibacterial compounds highlight the critical role of inventors in advancing healthcare solutions. His innovative work continues to impact the pharmaceutical industry positively.